quinazolines has been researched along with Renal Insufficiency in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bedir, S; Celik, E; Cikman, DI; Degerli, E; Demirci, NS; Demirelli, FH; Derin, S; Karadag, M; Oruc, K; Oztas, NS; Samanci, NS | 1 |
| Erb-Zohar, K; Halabi, A; Hulskotte, EGJ; Kropeit, D; Rübsamen-Schaeff, H; Scheuenpflug, J; Stobernack, HP; van Schanke, A; Zimmermann, H | 1 |
| Beckebaum, S; Cicinnati, VR; Kabar, I; Radtke, A | 1 |
| Abe, M; Antoku, S; Ito, H; Mifune, M; Nishio, S; Omoto, T; Shinozaki, M; Togane, M | 1 |
| Agerbaek, M; Cerbone, L; Collette, S; Daugaard, G; Marreaud, S; Sengeløv, L; Sternberg, CN; Van Herpen, C; Zhang, J | 1 |
| Belenfant, X; Bollée, G; Boucheix, C; Callard, P; Casal, I; Dussaule, JC; Endlich, K; Endlich, N; Flamant, M; Fligny, C; Galaup, A; Germain, S; Kopp, JB; Mesnard, L; Milon, M; Quaggin, SE; Rodenas, A; Rumpel, E; Sabaa, N; Salant, DJ; Schordan, E; Schordan, S; Sunnarborg, SW; Tharaux, PL; Threadgill, DW; Vandermeersch, S | 1 |
| Scheen, AJ; Van Gaal, LF | 1 |
| Encinas, J; Hayashi, N; Ohmura, T | 1 |
| McGill, JB; Newman, J; Patel, S; Sauce, C; Sloan, L; von Eynatten, M; Woerle, HJ | 1 |
| Bou Matar, RN; Klein, JD; Sands, JM | 1 |
| Akizawa, T; Hatamura, I; Negi, S; Orita, H; Saji, F; Sakaguchi, T; Shibata, M; Shiizaki, K | 1 |
| Anderton, JL; Gill, M; Notghi, A | 1 |
| Koike, Y; Mineshita, S; Mizoguchi, H; Nomura, Y | 1 |
2 review(s) available for quinazolines and Renal Insufficiency
| Article | Year |
|---|---|
Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?
Topics: Abatacept; Calcineurin Inhibitors; Everolimus; Humans; Immunoconjugates; Immunosuppression Therapy; Liver Transplantation; Mycophenolic Acid; Precision Medicine; Pyrroles; Quinazolines; Renal Insufficiency; Risk Factors; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2013 |
[Pharmacological and clinical profiles of the DPP-4 inhibitor linagliptin (Trazenta)].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Linagliptin; Purines; Quinazolines; Renal Insufficiency | 2012 |
5 trial(s) available for quinazolines and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.
Topics: Acetates; Aged; Antiviral Agents; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Quinazolines; Renal Insufficiency | 2017 |
Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; ErbB Receptors; Febrile Neutropenia; Female; Gemcitabine; Humans; International Cooperation; Lapatinib; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Quinazolines; Receptor, ErbB-2; Renal Insufficiency; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Renal Insufficiency; Young Adult | 2013 |
Renal haemodynamic effects of bunazosin retard and prazosin in mild to moderately hypertensive patients with normal or moderately impaired renal function.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Renal Insufficiency; Renal Plasma Flow, Effective | 1994 |
Pharmacokinetics and pharmacodynamics of bunazosin in patients with renal insufficiency.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Area Under Curve; Dose-Response Relationship, Drug; Female; Half-Life; Hemodynamics; Humans; Male; Middle Aged; Quinazolines; Renal Insufficiency; Time Factors | 1999 |
6 other study(ies) available for quinazolines and Renal Insufficiency
| Article | Year |
|---|---|
Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency.
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mutation; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Renal Insufficiency | 2021 |
Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment - retrospective observation study of Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Asian People; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Linagliptin; Male; Purines; Quinazolines; Renal Insufficiency; Retrospective Studies | 2015 |
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.
Topics: Analysis of Variance; Animals; Blotting, Western; Bone Marrow Transplantation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Flow Cytometry; Glomerulonephritis; Heparin-binding EGF-like Growth Factor; Humans; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney Glomerulus; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Phosphorylation; Podocytes; Quinazolines; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Statistics, Nonparametric; Tyrphostins | 2011 |
[Linagliptin (Trajenta): a selective DPP-4 inhibitor with limited renal elimination].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Purines; Quinazolines; Renal Insufficiency | 2012 |
Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
Topics: Animals; Antibiotics, Antineoplastic; Aquaporin 2; Creatinine; Doxorubicin; Epithelial Sodium Channels; ErbB Receptors; Erlotinib Hydrochloride; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Male; Nephrotic Syndrome; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Rats; Renal Insufficiency; Sodium Chloride Symporters; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1 | 2013 |
[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].
Topics: Animals; Cell Proliferation; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Hyperplasia; Intracellular Signaling Peptides and Proteins; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus, Dietary; Quinazolines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Time Factors; Transforming Growth Factor alpha | 2005 |